<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10320067</article-id>
    <article-id pub-id-type="pmid">37070199</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad279</article-id>
    <article-id pub-id-type="publisher-id">gkad279</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AlloReverse: multiscale understanding among hierarchical allosteric regulations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zha</surname>
          <given-names>Jinyin</given-names>
        </name>
        <aff><institution>State Key Laboratory of Functions and Applications of Medicinal Plants &amp; School of Pharmacy, Guizhou Medical University</institution>, <addr-line>Guizhou</addr-line><addr-line>550025</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Wenzhou Medical University</institution>, <addr-line>Wenzhou</addr-line><addr-line>325035</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Qian</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Xinyi</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lin</surname>
          <given-names>Weidong</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Nutshell Therapeutics</institution>, <addr-line>Shanghai</addr-line><addr-line>201210</addr-line>, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Tingting</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wei</surname>
          <given-names>Jiacheng</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Ziliang</given-names>
        </name>
        <aff><institution>Wenzhou Medical University</institution>, <addr-line>Wenzhou</addr-line><addr-line>325035</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lu</surname>
          <given-names>Xun</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Jing</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Department of Assisted Reproduction, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai 200011</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3902-2843</contrib-id>
        <name>
          <surname>Ni</surname>
          <given-names>Duan</given-names>
        </name>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Kun</given-names>
        </name>
        <aff><institution>Wenzhou Medical University</institution>, <addr-line>Wenzhou</addr-line><addr-line>325035</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Nutshell Therapeutics</institution>, <addr-line>Shanghai</addr-line><addr-line>201210</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Liang</given-names>
        </name>
        <aff><institution>Department of Biomedical Sciences, College of Veterinary Medicine and Life Sciences, City University of Hong Kong</institution>, <addr-line>Hong Kong</addr-line><addr-line>999077</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Lu</surname>
          <given-names>Xuefeng</given-names>
        </name>
        <!--xuefenglu163@163.com-->
        <aff><institution>Department of Assisted Reproduction, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai 200011</addr-line>, <country country="CN">China</country></aff>
        <xref rid="COR3" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1334-6292</contrib-id>
        <name>
          <surname>Lu</surname>
          <given-names>Shaoyong</given-names>
        </name>
        <!--lushaoyong@sjtu.edu.cn-->
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Institute of Energy Metabolism and Health, Shanghai Tenth People’s Hospital, Tongji University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200072</addr-line>, <country country="CN">China</country></aff>
        <xref rid="COR2" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6558-791X</contrib-id>
        <name>
          <surname>Zhang</surname>
          <given-names>Jian</given-names>
        </name>
        <!--Jian.zhang@sjtu.edu.cn-->
        <aff><institution>State Key Laboratory of Functions and Applications of Medicinal Plants &amp; School of Pharmacy, Guizhou Medical University</institution>, <addr-line>Guizhou</addr-line><addr-line>550025</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Wenzhou Medical University</institution>, <addr-line>Wenzhou</addr-line><addr-line>325035</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line><addr-line>200025</addr-line>, <country country="CN">China</country></aff>
        <aff><institution>School of Pharmaceutical Sciences, Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line><addr-line>450001</addr-line>, <country country="CN">China</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +86 21 63846590; Fax: +86 21 64154900; Email: <email>Jian.zhang@sjtu.edu.cn</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Shaoyong Lu. Tel: +86 21 63846590; Fax: +86 21 64154900; Email: <email>lushaoyong@sjtu.edu.cn</email></corresp>
      <corresp id="COR3">Correspondence may also be addressed to Xuefeng Lu. Tel: +86 21 63846590; Fax: +86 21 64154900; Email: <email>xuefenglu163@163.com</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first five authors should be regarded as Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-04-18">
      <day>18</day>
      <month>4</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>4</month>
      <year>2023</year>
    </pub-date>
    <volume>51</volume>
    <issue>W1</issue>
    <fpage>W33</fpage>
    <lpage>W38</lpage>
    <history>
      <date date-type="accepted">
        <day>05</day>
        <month>4</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>05</day>
        <month>3</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>07</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad279.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Increasing data in allostery are requiring analysis of coupling relationships among different allosteric sites on a single protein. Here, based on our previous efforts on reversed allosteric communication theory, we have developed AlloReverse, a web server for multiscale analysis of multiple allosteric regulations. AlloReverse integrates protein dynamics and machine learning to discover allosteric residues, allosteric sites and regulation pathways. Especially, AlloReverse could reveal hierarchical relationships between different pathways and couplings among allosteric sites, offering a whole map of allostery. The web server shows a good performance in re-emerging known allostery. Moreover, we applied AlloReverse to explore global allostery on CDC42 and SIRT3. AlloReverse predicted novel allosteric sites and allosteric residues in both systems, and the functionality of sites was validated experimentally. It also suggests a possible scheme for combined therapy or bivalent drugs on SIRT3. Taken together, AlloReverse is a novel workflow providing a complete regulation map and is believed to aid target identification, drug design and understanding of biological mechanisms. AlloReverse is freely available to all users at <ext-link xlink:href="https://mdl.shsmu.edu.cn/AlloReverse/" ext-link-type="uri">https://mdl.shsmu.edu.cn/AlloReverse/</ext-link> or <ext-link xlink:href="http://www.allostery.net/AlloReverse/" ext-link-type="uri">http://www.allostery.net/AlloReverse/</ext-link>.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>Identification of allosteric residues, allosteric sites, hierarchical regulation pathway and site-site couplings on protein surface.</p>
          </caption>
          <graphic xlink:href="gkad279figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Key R&amp;D Program of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100012166</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2022YFF1203005</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>81925034</award-id>
        <award-id>22237005</award-id>
        <award-id>22077082</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shanghai Municipal Education Commission</institution>
            <institution-id institution-id-type="DOI">10.13039/501100003395</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2019-01-07-00-01-E00036</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study</institution>
          </institution-wrap>
        </funding-source>
        <award-id>SN-ZJU-SIAS-007</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>High-Level Local Universities in Shanghai</institution>
          </institution-wrap>
        </funding-source>
        <award-id>SHSMU-ZDCX20212700</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shanghai Jiao Tong University School of Medicine</institution>
            <institution-id institution-id-type="DOI">10.13039/501100008233</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Key Research and Development Program of Ningxia Hui Autonomous Region</institution>
            <institution-id institution-id-type="DOI">10.13039/100016692</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2022CMG01002</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shanghai Health and Family Planning Commission</institution>
          </institution-wrap>
        </funding-source>
        <award-id>201940287</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shanghai Science and Technology Innovation Fund</institution>
          </institution-wrap>
        </funding-source>
        <award-id>22Y21900800</award-id>
        <award-id>22Y11906000</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shanghai Sailing Program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>21YF1422500</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Allostery (<xref rid="B1" ref-type="bibr">1–3</xref>) is the phenomenon that the function of an orthosteric site is regulated by a topologically distant allosteric site. Allostery is a fundamental way to tune the life process (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>) and has been applied manually for the treatment of human diseases (<xref rid="B6" ref-type="bibr">6–9</xref>), namely designing drugs bound to allosteric sites to realize a ‘remote control’. Allosteric drugs are an alternative solution to classically undruggable therapeutic targets. They are better in safety and selectivity compared to orthosteric drugs (<xref rid="B10" ref-type="bibr">10–12</xref>).</p>
    <p>Designing allosteric drugs requires multiscale knowledge of target proteins, including allosteric sites (<xref rid="B13" ref-type="bibr">13</xref>) for drug binding, allosteric residues for structure-based drug design and optimization, and residue pathways of allosteric regulation (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>) for mechanism exploration. This information could be revealed experimentally by large-scale mutagenesis (<xref rid="B16" ref-type="bibr">16</xref>) but with a huge cost of time and resources. A more rational way is to computationally (<xref rid="B17" ref-type="bibr">17–19</xref>) predict allosteric positions before biological validation. Several <italic toggle="yes">in silico</italic> tools (<xref rid="B20" ref-type="bibr">20–23</xref>) such as AllositePro (<xref rid="B24" ref-type="bibr">24</xref>) for predicting allosteric sites and ProteinLens (<xref rid="B25" ref-type="bibr">25</xref>) for locating regulating pathways were established, which have helped rational and efficient design of allosteric modulators, for example the first activators for both sirtuin 6 (<xref rid="B26" ref-type="bibr">26</xref>) and glutathione peroxidase 4 (<xref rid="B27" ref-type="bibr">27</xref>). However, the accumulating data of allostery (<xref rid="B28" ref-type="bibr">28</xref>) pose new challenges. Many proteins have more than one allosteric site (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>), and couplings among different allosteric sites have been observed theoretically (<xref rid="B31" ref-type="bibr">31</xref>) and experimentally (<xref rid="B32" ref-type="bibr">32–34</xref>). Currently, there are no easy-to-use tools to analyze biological relationships among different allosteric sites and regulations. Such relationships not only would show a complete map of allostery on protein surface, but also could hint at allosteric pharmacotherapy or design of bivalent drugs (<xref rid="B35" ref-type="bibr">35</xref>). Furthermore, there are limited tools for a complete multiscale analysis of protein allostery.</p>
    <p>Here, we introduce AlloReverse, a web server for multiscale analysis of multiple allosteric regulations. AlloReverse is built based on our previously developed ‘reversed allosteric communication theory’ (<xref rid="B36" ref-type="bibr">36–39</xref>), suggesting that in addition to classical regulation, allosteric sites are also regulated by orthosteric sites (<xref rid="B40" ref-type="bibr">40</xref>). The reversed nature of the theory, which adopts one start point (orthosteric site) and multiple end points (allosteric sites), enables synchronous analysis of different allosteric regulations on proteins. AlloReverse adopts protein dynamics, machine learning (ML) and shortest pathway algorithm to discover allosteric residues, allosteric sites, hierarchical regulation pathways and couplings among predicted sites. Our model was benchmarked to discover known allosteric sites on 77.6% proteins. Importantly, we applied AlloReverse to explore global allostery on cell division cycle 42 GTP-binding protein (CDC42) and sirtuin 3 (SIRT3). Novel predicted allosteric sites on both proteins were validated experimentally, and a possible scheme for drug design was proposed. Collectively, AlloReverse is a novel workflow to boost understanding of allostery and allosteric drug design.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>AlloReverse server</title>
      <p>AlloReverse is a server to predict multiscale allosteric information, including allosteric residues (residue scale), allosteric sites (domain scale) and allosteric pathways (protein scale), based on reversed allosteric communication theory. Especially, AlloReverse could reveal hierarchical relationships between different pathways and couplings among allosteric sites. The web server requires no login and is free to users around the world. The following parts are a brief overview of input, output and workflow (Figure <xref rid="F1" ref-type="fig">1</xref>). More details are given in Section S1 of Supplementary Data.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>Workflow of AlloReverse.</p>
        </caption>
        <graphic xlink:href="gkad279fig1" position="float"/>
      </fig>
    </sec>
    <sec id="SEC2-2">
      <title>AlloReverse input</title>
      <p>The process of input contains three steps. First, a protein structure with orthosteric ligand bound is uploaded, either from RCSB Protein Data Bank (<xref rid="B41" ref-type="bibr">41</xref>) via a valid PDB ID or from a manual file in PDB format. Considering computational time, structure file &gt;5 MB (roughly 6000 residues) is not allowed. Second, users are inquired whether to remove redundant chains. Finally, users could assign the orthosteric ligand in the structure file, either from a list of nonstandard residues or through manual specification.</p>
    </sec>
    <sec id="SEC2-3">
      <title>AlloReverse output</title>
      <p>Results are shown in ‘Job Queue’ when the calculation is finished, which contains four parts, as shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>. The first part includes an interactive window displaying protein structure and a summary of job information. The second part is a list of predicted allosteric sites with their confidences. Residues making up each site could be demonstrated in display window by clicking the ‘Show Site’ button. Detailed information of each site would be shown in a pop-up window after clicking the ‘More Info’ button. The new window has a table of physicochemical properties of the specific site, a 2D display of residues by hydrophobicity and reversed allosteric effect (RAE), and a mapping of variants or mutations to this site by data recorded in UniProt (<xref rid="B42" ref-type="bibr">42</xref>). Residues with high RAEs are supposed to be allosteric residues in this potential site. The third part is a figure of hierarchical residue pathways. In the figure, the orthosteric site is represented by a red circle in the middle, the predicted allosteric sites are shown by orange circles and residues in the pathways are displayed by blue circles. Arrows linking circles represent the routes of reversed allosteric communication. This diagram offers users with a whole map of allostery on protein surface and coupling relationships among different regulations. The last part is a heatmap describing regulations among predicted allosteric sites. The values range from 0 (white) to 1 (blue), where a larger value suggests a stronger regulation. Strongly coupled allosteric sites might be used for combined pharmacotherapy and design of bivalent modulators.</p>
      <p>All data could be downloaded by clicking the ‘Download Report’ button. Running time of AlloReverse ranges from 1 min for a protein with &lt;400 amino acids to half an hour for a protein with roughly 6000 amino acids. A step-by-step tutorial could be found in the ‘Help’ page on the server.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Identification of allosteric residues</title>
      <p>Pocket-like regions are first located on protein surface geometrically (<xref rid="B43" ref-type="bibr">43</xref>). RAE of a residue is then defined as its change of residue–residue interactions in the pocket between the <italic toggle="yes">apo</italic> and orthosteric ligand-bound (<italic toggle="yes">holo</italic>) states (<xref rid="B44" ref-type="bibr">44</xref>). RAE suggests response of each residue against orthosteric perturbation. Residues with high RAE are supposed to be allosteric residues.</p>
    </sec>
    <sec id="SEC2-5">
      <title>Recognition of allosteric sites</title>
      <p>Allosteric sites are recognized with an AdaBoost classifier (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B45" ref-type="bibr">45–47</xref>), by judging which pocket-like regions detected in the previous step are allosteric sites. AdaBoost is a serial ensemble learning method, which trains the new classifier focusing on misclassified samples of the old classifiers. The classifier adopts hydrophobicity, flexibility and RAE of the pocket (sum of RAEs of residues in it) as input features. The model would also output prediction confidence for each potential site.</p>
    </sec>
    <sec id="SEC2-6">
      <title>Prediction of hierarchical regulation pathways</title>
      <p>An important feature of AlloReverse is that it could predict all allosteric regulations in one shot and analyze their coupling relationships, based on the reverse nature of reversed allosteric communication theory. Following previous efforts on allosteric mechanisms (<xref rid="B48" ref-type="bibr">48–50</xref>), regulation pathway of a predicted site is defined to be the shortest route from an orthosteric ligand to the residue in site with the highest RAE, where ‘distances’ between residues are calculated as the reciprocal of their mean motion correlation.</p>
    </sec>
    <sec id="SEC2-7">
      <title>Evaluation of site–site coupling</title>
      <p>Since different regulation pathways would share some residues, it is believed that these allosteric sites might influence each other. Based on a previous hierarchical regulation pathway, the degree of site A coupled by site B is defined as the proportion of shared residues in the pathway toward site A, i.e. the coupling is usually asymmetric. Strongly coupled sites may be applied for combined allosteric therapy or design of bivalent drugs.</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>PERFORMANCE OF ALLOREVERSE</title>
    <p>The performance of AlloReverse relies on how good the ML model could discriminate allosteric sites from pocket-like regions. The power of classification was benchmarked on a test set (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S2–S5</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>) of 58 proteins, which contains 926 pocket-like regions and 83 of them are labeled as ‘allosteric sites’. The distribution of descriptor values and the ratio of labeled sites in the test set were found to be statistically same as those in the training set (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S4</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>), ensuring the validity of benchmarking. Our model could recall 71.0% labeled allosteric sites and could re-emerge at least one allosteric site for 77.6% proteins in the test set. These data have shown good sensibility of the model in recognizing allosteric sites on complex protein surface. The classification power was further testified by receiver operating characteristic (ROC) curve (<xref rid="B20" ref-type="bibr">20</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6</xref>) of the model. The area under ROC curve was calculated to be 0.758, so that AlloReverse could significantly differentiate allosteric sites from other sites. All these data have ensured the predicting power of AlloReverse.</p>
  </sec>
  <sec id="SEC4">
    <title>EXAMPLES</title>
    <sec id="SEC4-1">
      <title>Case 1: allosteric sites and allosteric residues on CDC42</title>
      <p>CDC42 is a GTPase regulating cytoskeleton during cell division (<xref rid="B51" ref-type="bibr">51</xref>,<xref rid="B52" ref-type="bibr">52</xref>). It is a star target in the field of immunosuppression and anti-inflammation (<xref rid="B53" ref-type="bibr">53</xref>). There are no reported allosteric sites on CDC42. We analyzed CDC42 with GMP bound at the orthosteric site [PDB ID 2QRZ (<xref rid="B54" ref-type="bibr">54</xref>)] using AlloReverse. An allosteric site close to the GMP orthosteric site was predicted, as shown in Figure <xref rid="F2" ref-type="fig">2A</xref>, formed by an α-helix (residues 65–70) and a loop (residues 56–64). To validate the prediction, we performed site-directed mutagenesis, including L67A, R68A, L70A and S71A. The four residues, which are on the α-helix, were chosen because they are relatively distant from the orthosteric site. We found that the decreased degree in the GTP binding levels was significantly observed in the L67A, R68A and S71A variants (Figure <xref rid="F2" ref-type="fig">2B</xref>). CDC42 is activated by GTP binding. Thus, the decreased GTP binding levels in the variants suggest the potential of this site in the regulation of CDC42 activity (see Section S2 of <xref rid="sup1" ref-type="supplementary-material">Supplementary Data and</xref><xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S7A</xref> for experimental details). Interestingly, we found that L67 was also predicted to be an allosteric residue (Figure <xref rid="F2" ref-type="fig">2C</xref>), with the highest RAE in the site. These data have demonstrated the power of discovering a novel allosteric site and key residues using AlloReverse.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Examples of AlloReverse. CDC42: (<bold>A</bold>) Novel allosteric site predicted by AlloReverse. (<bold>B</bold>) Validation of allosteric site by mutagenesis. The <italic toggle="yes">Y</italic>-axis means the degree of GTP binding by CDC42. (<bold>C</bold>) RAE of residues in the novel allosteric pocket. SIRT3: (<bold>D</bold>) Novel allosteric sites predicted by AlloReverse. Value under site name represents the prediction confidence. (<bold>E</bold>) Validation of allosteric site by mutagenesis. The <italic toggle="yes">Y</italic>-axis means the degree of deacetylation by SIRT3. (<bold>F</bold>) Hierarchical regulation pathway predicted on SIRT3. (<bold>G</bold>) Site–site couplings predicted on SIRT3.</p>
        </caption>
        <graphic xlink:href="gkad279fig2" position="float"/>
      </fig>
    </sec>
    <sec id="SEC4-2">
      <title>Case 2: allosteric sites and hierarchical regulating pathways on SIRT3</title>
      <p>SIRT3 is a deacetylase able to regulate many proteins in mitochondria (<xref rid="B55" ref-type="bibr">55</xref>,<xref rid="B56" ref-type="bibr">56</xref>). It plays important roles in development of cancer and cardiovascular disease (<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>). Previous research works have reported two shallow allosteric sites on SIRT3 [PDB IDs 4C78 (<xref rid="B59" ref-type="bibr">59</xref>) and 5Y4H (<xref rid="B60" ref-type="bibr">60</xref>)]. We analyzed SIRT3 with carba-NAD bound at the orthosteric site [PDB ID 4FVT (<xref rid="B54" ref-type="bibr">54</xref>)] using AlloReverse. As shown in Figure <xref rid="F2" ref-type="fig">2D</xref>, three allosteric sites were predicted. All three sites are located differently to the previous report, although site 2 is close to the ligand of 4C78 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8</xref>). The validity of site 1, which has the highest confidence, was further proved by mutagenesis (see Section S2 of <xref rid="sup1" ref-type="supplementary-material">Supplementary Data and</xref><xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S7B</xref> for experimental details), where a significant decrease in deacetylation activity was found in response to the single P201A, R235A, F251A and S253A variants in the site (Figure <xref rid="F2" ref-type="fig">2E</xref>). In addition, sites 1 and 3 are coupled since they share four residues on regulation pathways, while regulation toward site 2 adopts a completely different direction (Figure <xref rid="F2" ref-type="fig">2F</xref> and G). This result suggests that further study could focus on both sites 1 and 3 for design of bivalent molecules or allosteric pharmacotherapy.</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC5">
    <title>DISCUSSION</title>
    <p>Allostery is a remarkable technique for drug design, especially for classically undruggable targets (<xref rid="B6" ref-type="bibr">6</xref>). Allosteric drugs are praised for better safety, selectivity and functional diversity (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>). Though many computational tools have already been developed to facilitate difficulties in studying allostery (<xref rid="B22" ref-type="bibr">22</xref>), accumulating data (<xref rid="B28" ref-type="bibr">28</xref>) are calling for coupling analysis among different allosteric regulations on a single protein, which might hint at the design of bivalent drugs and combined allosteric drug use. Also, tools are required to produce different scales of allosteric data, including allosteric residues (residue scale), allosteric sites (domain scale) and allosteric pathways (protein scale) in one shot. Under such demand, we have introduced AlloReverse, a web server for analyzing multiscale and multiple allosteric regulations on protein surface. The server could predict regulating residues, allosteric sites, allosteric pathways and site–site couplings based on reversed allosteric communication theory. Importantly, AlloReverse could reveal the hierarchical relationships among different regulations. AlloReverse was applied for predicting novel allosteric sites and site–site couplings on CDC42 and SIRT3. Currently, AlloReverse requires orthosteric ligand-bound structure as input, which is numbered. Further effort could be focused on automatic assignment of orthosteric perturbations in the <italic toggle="yes">apo</italic> structures. In addition, the prediction of allosteric sites and site–site couplings requires further validation. Cumulatively, AlloReverse is a novel workflow for discovering a whole map of allostery. It is believed to accelerate the design of allosteric drugs.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC6">
    <title>DATA AVAILABILITY</title>
    <p>AlloReverse is freely available to all users at <ext-link xlink:href="https://mdl.shsmu.edu.cn/AlloReverse//" ext-link-type="uri">https://mdl.shsmu.edu.cn/AlloReverse/</ext-link> or <ext-link xlink:href="http://www.allostery.net/AlloReverse/" ext-link-type="uri">http://www.allostery.net/AlloReverse/</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkad279_Supplemental_File</label>
      <media xlink:href="gkad279_supplemental_file.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank Dr Jialin Shang at Cornell University and Mr Chenggong Hui at Max Planck Institute for Multidisciplinary Sciences for detailed advice on our web server.</p>
  </ack>
  <sec id="SEC7">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad279#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC8">
    <title>FUNDING</title>
    <p>National Key R&amp;D Program of China [2022YFF1203005 to J. Zhang]; National Natural Science Foundation of China [81925034 and 22237005 to J. Zhang; 22077082 to S.L.]; Innovation Program of Shanghai Municipal Education Commission [2019-01-07-00-01-E00036 to J. Zhang]; Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study [SN-ZJU-SIAS-007 to J. Zhang]; Innovative Research Team of High-Level Local Universities in Shanghai [SHSMU-ZDCX20212700 to J. Zhang]; GuangCi Professorship Program of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine [to J. Zhang]; Key Research and Development Program of Ningxia Hui Autonomous Region [2022CMG01002 to J. Zhang]; Shanghai Health and Family Planning Commission [201940287 to Xuefeng Lu]; Shanghai Science and Technology Innovation Fund [22Y21900800 and 22Y11906000 to Xuefeng Lu]; Shanghai Sailing Program [21YF1422500 to Q.L.]. Funding for open access charge: National Natural Science Foundation of China.</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>L.</given-names></string-name></person-group><article-title>Protein topology and allostery</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2020</year>; <volume>62</volume>:<fpage>158</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">32066080</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>H.</given-names></string-name></person-group><article-title>Dynamic protein allosteric regulation and disease</article-title>. <source>Adv. Exp. Med. Biol.</source><year>2019</year>; <volume>1163</volume>:<fpage>25</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">31707698</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ribeiro</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Ortiz</surname><given-names>V.</given-names></string-name></person-group><article-title>A chemical perspective on allostery</article-title>. <source>Chem. Rev.</source><year>2016</year>; <volume>116</volume>:<fpage>6488</fpage>–<lpage>6502</lpage>.<pub-id pub-id-type="pmid">26741913</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chaneton</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hillmann</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>A.C.L.</given-names></string-name>, <string-name><surname>Maddocks</surname><given-names>O.D.K.</given-names></string-name>, <string-name><surname>Chokkathukalam</surname><given-names>A.</given-names></string-name>, <string-name><surname>Coyle</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Jankevics</surname><given-names>A.</given-names></string-name>, <string-name><surname>Holding</surname><given-names>F.P.</given-names></string-name>, <string-name><surname>Vousden</surname><given-names>K.H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Serine is a natural ligand and allosteric activator of pyruvate kinase M2</article-title>. <source>Nature</source>. <year>2012</year>; <volume>491</volume>:<fpage>458</fpage>–<lpage>462</lpage>.<pub-id pub-id-type="pmid">23064226</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sasaki</surname><given-names>R.</given-names></string-name>, <string-name><surname>Chiba</surname><given-names>H.</given-names></string-name></person-group><article-title>Role and induction of 2,3-bisphosphoglycerate synthase</article-title>. <source>Mol. Cell. Biochem.</source><year>1983</year>; <volume>53</volume>:<fpage>247</fpage>–<lpage>256</lpage>.<pub-id pub-id-type="pmid">6312283</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>He</surname><given-names>X.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Allosteric modulator discovery: from serendipity to structure-based design</article-title>. <source>J. Med. Chem.</source><year>2019</year>; <volume>62</volume>:<fpage>6405</fpage>–<lpage>6421</lpage>.<pub-id pub-id-type="pmid">30817889</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kinoshita</surname><given-names>T.</given-names></string-name></person-group><article-title>Protein allostery in rational drug design</article-title>. <source>Adv. Exp. Med. Biol.</source><year>2019</year>; <volume>1163</volume>:<fpage>45</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">31707699</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>H.</given-names></string-name></person-group><article-title>Allostery in drug development</article-title>. <source>Adv. Exp. Med. Biol.</source><year>2019</year>; <volume>1163</volume>:<fpage>1</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">31707697</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>He</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name></person-group><article-title>Drugging K-Ras<sup>G12C</sup> through covalent inhibitors: mission possible?</article-title>. <source>Pharmacol. Ther.</source><year>2019</year>; <volume>202</volume>:<fpage>1</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">31233765</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Changeux</surname><given-names>J.P.</given-names></string-name></person-group><article-title>The concept of allosteric modulation: an overview</article-title>. <source>Drug. Discov. Today Technol.</source><year>2013</year>; <volume>10</volume>:<fpage>223</fpage>–<lpage>228</lpage>.</mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric drugs and mutations: chances, challenges, and necessity</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2020</year>; <volume>62</volume>:<fpage>149</fpage>–<lpage>157</lpage>.<pub-id pub-id-type="pmid">32062398</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.Q.</given-names></string-name>, <string-name><surname>Kong</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Z.T.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Computational elucidation of allosteric communication in proteins for allosteric drug design</article-title>. <source>Drug Discov. Today</source>. <year>2022</year>; <volume>27</volume>:<fpage>2226</fpage>–<lpage>2234</lpage>.<pub-id pub-id-type="pmid">35314339</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Altintel</surname><given-names>B.</given-names></string-name>, <string-name><surname>Acar</surname><given-names>B.</given-names></string-name>, <string-name><surname>Erman</surname><given-names>B.</given-names></string-name>, <string-name><surname>Haliloglu</surname><given-names>T.</given-names></string-name></person-group><article-title>Subsets of slow dynamic modes reveal global information sources as allosteric sites</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167644</fpage>.<pub-id pub-id-type="pmid">35644497</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haliloglu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Hacisuleyman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Erman</surname><given-names>B.</given-names></string-name></person-group><article-title>Prediction of allosteric communication pathways in proteins</article-title>. <source>Bioinformatics</source>. <year>2022</year>; <volume>38</volume>:<fpage>3590</fpage>–<lpage>3599</lpage>.<pub-id pub-id-type="pmid">35674396</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Jain</surname><given-names>A.</given-names></string-name>, <string-name><surname>McDonald</surname><given-names>L.R.</given-names></string-name>, <string-name><surname>Gambogi</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Dokholyan</surname><given-names>N.V.</given-names></string-name></person-group><article-title>Mapping allosteric communications within individual proteins</article-title>. <source>Nat. Commun.</source><year>2020</year>; <volume>11</volume>:<fpage>3862</fpage>.<pub-id pub-id-type="pmid">32737291</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Faure</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Domingo</surname><given-names>J.</given-names></string-name>, <string-name><surname>Schmiedel</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Hidalgo-Carcedo</surname><given-names>C.</given-names></string-name>, <string-name><surname>Diss</surname><given-names>G.</given-names></string-name>, <string-name><surname>Lehner</surname><given-names>B.</given-names></string-name></person-group><article-title>Mapping the energetic and allosteric landscapes of protein binding domains</article-title>. <source>Nature</source>. <year>2022</year>; <volume>604</volume>:<fpage>175</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">35388192</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>116</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">31701124</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pei</surname><given-names>J.</given-names></string-name></person-group><article-title>CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>374</fpage>–<lpage>379</lpage>.</mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Felline</surname><given-names>A.</given-names></string-name>, <string-name><surname>Seeber</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fanelli</surname><given-names>F.</given-names></string-name></person-group><article-title>webPSN v2.0: a webserver to infer fingerprints of structural communication in biomacromolecules</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>94</fpage>–<lpage>103</lpage>.</mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname><given-names>K.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>AlloDriver: a method for the identification and analysis of cancer driver targets</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>315</fpage>–<lpage>321</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Song</surname><given-names>K.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>451</fpage>–<lpage>458</lpage>.</mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Chai</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Along the allostery stream: recent advances in computational methods for allosteric drug discovery</article-title>. <source>WIREs Comput. Mol. Sci.</source><year>2021</year>; <volume>12</volume>:<fpage>e1585</fpage>.</mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zha</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kong</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Explaining and predicting allostery with allosteric database and modern analytical techniques</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167481</fpage>–<lpage>167499</lpage>.<pub-id pub-id-type="pmid">35131258</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname><given-names>K.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Improved method for the identification and validation of allosteric sites</article-title>. <source>J. Chem. Inf. Model.</source><year>2017</year>; <volume>57</volume>:<fpage>2358</fpage>–<lpage>2363</lpage>.<pub-id pub-id-type="pmid">28825477</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mersmann</surname><given-names>S.F.</given-names></string-name>, <string-name><surname>Stromich</surname><given-names>L.</given-names></string-name>, <string-name><surname>Song</surname><given-names>F.J.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>N.</given-names></string-name>, <string-name><surname>Vianello</surname><given-names>F.</given-names></string-name>, <string-name><surname>Barahona</surname><given-names>M.</given-names></string-name>, <string-name><surname>Yaliraki</surname><given-names>S.N.</given-names></string-name></person-group><article-title>ProteinLens: a web-based application for the analysis of allosteric signalling on atomistic graphs of biomolecules</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>551</fpage>–<lpage>558</lpage>.</mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>W.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Song</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Identification of a cellularly active SIRT6 allosteric activator</article-title>. <source>Nat. Chem. Biol.</source><year>2018</year>; <volume>14</volume>:<fpage>1118</fpage>–<lpage>1126</lpage>.<pub-id pub-id-type="pmid">30374165</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>X.</given-names></string-name>, <string-name><surname>Conrad</surname><given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Angeli</surname><given-names>J.P.F.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>L.</given-names></string-name></person-group><article-title>Novel allosteric activators for ferroptosis regulator glutathione peroxidase 4</article-title>. <source>J. Med. Chem.</source><year>2019</year>; <volume>62</volume>:<fpage>266</fpage>–<lpage>275</lpage>.<pub-id pub-id-type="pmid">29688708</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Song</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>He</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Unraveling allosteric landscapes of allosterome with ASD</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>394</fpage>–<lpage>401</lpage>.</mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Allosteric binding sites at the receptor–lipid bilayer interface: novel targets for GPCR drug discovery</article-title>. <source>Drug Discov. Today</source>. <year>2021</year>; <volume>26</volume>:<fpage>690</fpage>–<lpage>703</lpage>.<pub-id pub-id-type="pmid">33301977</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>S.</given-names></string-name></person-group><article-title>GPCR allosteric modulator discovery</article-title>. <source>Adv. Exp. Med. Biol.</source><year>2019</year>; <volume>1163</volume>:<fpage>225</fpage>–<lpage>251</lpage>.<pub-id pub-id-type="pmid">31707706</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>W.</given-names></string-name></person-group><article-title>D3Pockets: a method and web server for systematic analysis of protein pocket dynamics</article-title>. <source>J. Chem. Inf. Model.</source><year>2019</year>; <volume>59</volume>:<fpage>3353</fpage>–<lpage>3358</lpage>.<pub-id pub-id-type="pmid">31265282</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Hembre</surname><given-names>E.J.</given-names></string-name>, <string-name><surname>Goldsmith</surname><given-names>P.J.</given-names></string-name>, <string-name><surname>Beck</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Svensson</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Willard</surname><given-names>F.S.</given-names></string-name>, <string-name><surname>Bruns</surname><given-names>R.F.</given-names></string-name></person-group><article-title>Mutual cooperativity of three allosteric sites on the dopamine D1 receptor</article-title>. <source>Mol. Pharmacol.</source><year>2023</year>; <volume>103</volume>:<fpage>176</fpage>–<lpage>187</lpage>.<pub-id pub-id-type="pmid">36804203</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chan</surname><given-names>T.O.</given-names></string-name>, <string-name><surname>Armen</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Yadav</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shah</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Tiegs</surname><given-names>B.C.</given-names></string-name>, <string-name><surname>Keny</surname><given-names>N.</given-names></string-name>, <string-name><surname>Blumhof</surname><given-names>B.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Rodeck</surname><given-names>U.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A tripartite cooperative mechanism confers resistance of the protein kinase A catalytic subunit to dephosphorylation</article-title>. <source>J. Biol. Chem.</source><year>2020</year>; <volume>295</volume>:<fpage>3316</fpage>–<lpage>3329</lpage>.<pub-id pub-id-type="pmid">31964716</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Skovpen</surname><given-names>Y.V.</given-names></string-name>, <string-name><surname>Conly</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Sanders</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Palmer</surname><given-names>D.R.</given-names></string-name></person-group><article-title>Biomimetic design results in a potent allosteric inhibitor of dihydrodipicolinate synthase from <italic toggle="yes">Campylobacter jejuni</italic></article-title>. <source>J. Am. Chem. Soc.</source><year>2016</year>; <volume>138</volume>:<fpage>2014</fpage>–<lpage>2020</lpage>.<pub-id pub-id-type="pmid">26836694</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>N.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>DNA-modularized construction of bivalent ligands precisely regulates receptor binding and activation</article-title>. <source>Chem</source>. <year>2023</year>; <pub-id pub-id-type="doi">10.1016/j.chempr.2022.12.002</pub-id>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Su</surname><given-names>J.-C.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>S.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells</article-title>. <source>Acta Pharm. Sin. B</source>. <year>2022</year>; <volume>12</volume>:<fpage>876</fpage>–<lpage>889</lpage>.<pub-id pub-id-type="pmid">35256952</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qiu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Fu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name></person-group><article-title>Untangling dual-targeting therapeutic mechanism of epidermal growth factor receptor (EGFR) based on reversed allosteric communication</article-title>. <source>Pharmaceutics</source>. <year>2021</year>; <volume>13</volume>:<fpage>747</fpage>–<lpage>774</lpage>.<pub-id pub-id-type="pmid">34070173</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>J.</given-names></string-name>, <string-name><surname>He</surname><given-names>X.</given-names></string-name>, <string-name><surname>Rehman</surname><given-names>A.U.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Qiu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy</article-title>. <source>Chem. Sci.</source><year>2020</year>; <volume>12</volume>:<fpage>464</fpage>–<lpage>476</lpage>.<pub-id pub-id-type="pmid">34163609</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kong</surname><given-names>R.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>Harnessing reversed allosteric communication: a novel strategy for allosteric drug discovery</article-title>. <source>J. Med. Chem.</source><year>2021</year>; <volume>64</volume>:<fpage>17728</fpage>–<lpage>17743</lpage>.<pub-id pub-id-type="pmid">34878270</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Reversing allosteric communication: from detecting allosteric sites to inducing and tuning targeted allosteric response</article-title>. <source>PLoS Comput. Biol.</source><year>2018</year>; <volume>14</volume>:<fpage>1006228</fpage>.</mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Bhikadiya</surname><given-names>C.</given-names></string-name>, <string-name><surname>Bi</surname><given-names>C.X.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Crichlow</surname><given-names>G.V.</given-names></string-name>, <string-name><surname>Christie</surname><given-names>C.H.</given-names></string-name>, <string-name><surname>Dalenberg</surname><given-names>K.</given-names></string-name>, <string-name><surname>Di Costanzo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Duarte</surname><given-names>J.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D437</fpage>–<lpage>D451</lpage>.<pub-id pub-id-type="pmid">33211854</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bateman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Martin</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Orchard</surname><given-names>S.</given-names></string-name>, <string-name><surname>Magrane</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ahmad</surname><given-names>S.</given-names></string-name>, <string-name><surname>Alpi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Bowler-Barnett</surname><given-names>E.H.</given-names></string-name>, <string-name><surname>Britto</surname><given-names>R.</given-names></string-name>, <string-name><surname>Cukura</surname><given-names>A.</given-names></string-name>, <string-name><surname>Denny</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>UniProt: the Universal Protein Knowledgebase in 2023</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>51</volume>:<fpage>D523</fpage>–<lpage>D531</lpage>.</mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Le Guilloux</surname><given-names>V.</given-names></string-name>, <string-name><surname>Schmidtke</surname><given-names>P.</given-names></string-name>, <string-name><surname>Tuffery</surname><given-names>P</given-names></string-name></person-group><article-title>Fpocket: an open source platform for ligand pocket detection</article-title>. <source>BMC Bioinformatics</source>. <year>2009</year>; <volume>10</volume>:<fpage>168</fpage>.<pub-id pub-id-type="pmid">19486540</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Krieger</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kaya</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kaynak</surname><given-names>B.</given-names></string-name>, <string-name><surname>Mikulska-Ruminska</surname><given-names>K.</given-names></string-name>, <string-name><surname>Doruker</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.C.</given-names></string-name>, <string-name><surname>Bahar</surname><given-names>I.</given-names></string-name></person-group><article-title>ProDy 2.0: increased scale and scope after 10 years of protein dynamics modelling with Python</article-title>. <source>Bioinformatics</source>. <year>2021</year>; <volume>37</volume>:<fpage>3657</fpage>–<lpage>3659</lpage>.<pub-id pub-id-type="pmid">33822884</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pedregosa</surname><given-names>F.</given-names></string-name>, <string-name><surname>Varoquaux</surname><given-names>G.</given-names></string-name>, <string-name><surname>Gramfort</surname><given-names>A.</given-names></string-name>, <string-name><surname>Michel</surname><given-names>V.</given-names></string-name>, <string-name><surname>Thirion</surname><given-names>B.</given-names></string-name>, <string-name><surname>Grisel</surname><given-names>O.</given-names></string-name>, <string-name><surname>Blondel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Prettenhofer</surname><given-names>P.</given-names></string-name>, <string-name><surname>Weiss</surname><given-names>R.</given-names></string-name>, <string-name><surname>Dubourg</surname><given-names>V.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Scikit-learn: machine learning in Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>; <volume>12</volume>:<fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Freund</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Schapire</surname><given-names>R.E.</given-names></string-name></person-group><article-title>A decision-theoretic generalization of on-line learning and an application to boosting</article-title>. <source>J. Comput. Syst. Sci.</source><year>1997</year>; <volume>55</volume>:<fpage>119</fpage>–<lpage>139</lpage>.</mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>ASBench: benchmarking sets for allosteric discovery</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>2598</fpage>–<lpage>2600</lpage>.<pub-id pub-id-type="pmid">25810427</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dube</surname><given-names>N.</given-names></string-name>, <string-name><surname>Khan</surname><given-names>S.H.</given-names></string-name>, <string-name><surname>Sasse</surname><given-names>R.</given-names></string-name>, <string-name><surname>Okafor</surname><given-names>C.D.</given-names></string-name></person-group><article-title>Identification of an evolutionarily conserved allosteric network in steroid receptors</article-title>. <source>J. Chem. Inf. Model.</source><year>2023</year>; <volume>63</volume>:<fpage>571</fpage>–<lpage>582</lpage>.<pub-id pub-id-type="pmid">36594606</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hua</surname><given-names>C.</given-names></string-name>, <string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name></person-group><article-title>Markov state models and molecular dynamics simulations reveal the conformational transition of the intrinsically disordered hypervariable region of K-Ras4B to the ordered conformation</article-title>. <source>J. Chem. Inf. Model.</source><year>2022</year>; <volume>62</volume>:<fpage>4222</fpage>–<lpage>4231</lpage>.<pub-id pub-id-type="pmid">35994329</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Song</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>The mechanism of ATP-dependent allosteric protection of Akt kinase phosphorylation</article-title>. <source>Structure</source>. <year>2015</year>; <volume>23</volume>:<fpage>1725</fpage>–<lpage>1734</lpage>.<pub-id pub-id-type="pmid">26256536</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kukimoto-Niino</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ihara</surname><given-names>K.</given-names></string-name>, <string-name><surname>Murayama</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shirouzu</surname><given-names>M.</given-names></string-name></person-group><article-title>Structural insights into the small GTPase specificity of the DOCK guanine nucleotide exchange factors</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2021</year>; <volume>71</volume>:<fpage>249</fpage>–<lpage>258</lpage>.<pub-id pub-id-type="pmid">34507037</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fukata</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kaibuchi</surname><given-names>K.</given-names></string-name></person-group><article-title>Rho-family GTPases in cadherin-mediated cell–cell adhesion</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source><year>2001</year>; <volume>2</volume>:<fpage>887</fpage>–<lpage>897</lpage>.<pub-id pub-id-type="pmid">11733768</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Melendez</surname><given-names>J.</given-names></string-name>, <string-name><surname>Grogg</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Y.</given-names></string-name></person-group><article-title>Signaling role of Cdc42 in regulating mammalian physiology</article-title>. <source>J. Biol. Chem.</source><year>2011</year>; <volume>286</volume>:<fpage>2375</fpage>–<lpage>2381</lpage>.<pub-id pub-id-type="pmid">21115489</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phillips</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Calero</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chan</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ramachandran</surname><given-names>S.</given-names></string-name>, <string-name><surname>Cerione</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42</article-title>. <source>J. Biol. Chem.</source><year>2008</year>; <volume>283</volume>:<fpage>14153</fpage>–<lpage>14164</lpage>.<pub-id pub-id-type="pmid">18348980</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>H.G.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>He</surname><given-names>R.R.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>B.</given-names></string-name></person-group><article-title>Mitochondrial sirtuin 3: new emerging biological function and therapeutic target</article-title>. <source>Theranostics</source>. <year>2020</year>; <volume>10</volume>:<fpage>8315</fpage>–<lpage>8342</lpage>.<pub-id pub-id-type="pmid">32724473</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torrens-Mas</surname><given-names>M.</given-names></string-name>, <string-name><surname>Oliver</surname><given-names>J.</given-names></string-name>, <string-name><surname>Roca</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sastre-Serra</surname><given-names>J.</given-names></string-name></person-group><article-title>SIRT3: oncogene and tumor suppressor in cancer</article-title>. <source>Cancers (Basel)</source>. <year>2017</year>; <volume>9</volume>:<fpage>90</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">28704962</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.D.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>Z.J.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>M.X.</given-names></string-name></person-group><article-title>SIRT3 in cardiovascular diseases: emerging roles and therapeutic implications</article-title>. <source>Int. J. Cardiol.</source><year>2016</year>; <volume>220</volume>:<fpage>700</fpage>–<lpage>705</lpage>.<pub-id pub-id-type="pmid">27393852</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Fu</surname><given-names>L.L.</given-names></string-name>, <string-name><surname>Wen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J.</given-names></string-name></person-group><article-title>Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer</article-title>. <source>Cell Death Dis.</source><year>2014</year>; <volume>5</volume>:<fpage>e1047</fpage>.<pub-id pub-id-type="pmid">24503539</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nguyen</surname><given-names>G.T.T.</given-names></string-name>, <string-name><surname>Gertz</surname><given-names>M.</given-names></string-name>, <string-name><surname>Steegborn</surname><given-names>C.</given-names></string-name></person-group><article-title>Crystal structures of Sirt3 complexes with 4′-bromo-resveratrol reveal binding sites and inhibition mechanism</article-title>. <source>Chem. Biol.</source><year>2013</year>; <volume>20</volume>:<fpage>1375</fpage>–<lpage>1385</lpage>.<pub-id pub-id-type="pmid">24211137</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakamura</surname><given-names>F.</given-names></string-name>, <string-name><surname>Kudo</surname><given-names>N.</given-names></string-name>, <string-name><surname>Tomachi</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Nakata</surname><given-names>A.</given-names></string-name>, <string-name><surname>Takemoto</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ito</surname><given-names>A.</given-names></string-name>, <string-name><surname>Tabei</surname><given-names>H.</given-names></string-name>, <string-name><surname>Arai</surname><given-names>D.</given-names></string-name>, <string-name><surname>de Voogd</surname><given-names>N.</given-names></string-name>, <string-name><surname>Yoshida</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Halistanol sulfates I and J, new SIRT1-3 inhibitory steroid sulfates from a marine sponge of the genus <italic toggle="yes">Halichondria</italic></article-title>. <source>J. Antibiot.</source><year>2018</year>; <volume>71</volume>:<fpage>273</fpage>–<lpage>278</lpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
